Benefiting from Growth Opportunities: ISPE Brazil Affiliate

A Flourishing Market

Brazil is the largest country in South America and, with a population of 212 million, it is the sixth most populous country in the world. According to a 2019 report from the Brazilian pharma industry trade group Interfarma, the Brazilian pharmaceutical market grew 11% in 2018, reaching R$90 billion (US$20.12 billion). Interfarma projects that the market will continue to grow, becoming the fifth largest in the world in the next few years.Interfarma—Associação da Indústria Farmacêutica de Pesquisa. “Interfarma Guide.” 2019. https://www.interfarma.org.br/public/files/biblioteca/interfarma-5C-s-2019-guide-interfarma1.pdf

This growth is being supported through the work of ANVISA, Brazil’s national health surveillance agency, which has been implementing new regulations and guidelines intended to align the Brazilian pharma industry with international standards. In late 2016, ANVISA was accepted as a new member agency of ICH. ANVISA has also applied to join the Pharmaceutical Inspection Co-operation Scheme (PIC/S).

“When ANVISA aligned with ICH and PIC/S, they released new regulations,” explained ISPE Brazil Affiliate president Mario Brenga Giampietro. “This is bringing a lot of opportunities to ISPE in Brazil. ISPE is always ahead of new technologies, and our guidelines will help companies to become compliant with these regulations.”

Affiliate Growth

To respond to these opportunities, the Brazil Affiliate is transforming. The Affiliate increased its number of Communities of Practice (CoPs) from six in 2018 to 17 in 2019. “We found that the best way to allow people to discuss things, share knowledge, and improve networking is through these committees,” said Giampietro. “In October 2018, we had a big meeting and presented these ideas to people in ISPE who are deeply involved in the pharmaceutical market. Then we invited them to help start or be part of these Communities of Practices.”

Founded in 1999, the ISPE Brazil Affiliate is based in the country’s largest city, São Paulo, which is also home to a cluster of pharmaceutical companies. In the last year, the Affiliate has seen its membership increase by over 38% to 163 members, including representatives from other sectors of the life sciences such as veterinary sciences, cosmetics, and medical devices. “Our creation of the CoPs has helped us gain more volunteers and associates here in Brazil,” Giampietro said.

As the membership has grown, the Affiliate has expanded the number of events it hosts. In 2019, the Affiliate held 42 events—four more than in 2018, with an impressive 38% increase in event attendance. Almost all the events were held in or near São Paulo, and all were on technical subjects, said Giampietro.

Strengthening International Relationships

Giampietro hopes to improve the Brazil Affiliate’s relationships with other ISPE Chapters and Affiliates around the world. “ISPE’s global network has been very helpful for us,” he said. “The relationship between the Brazil Affiliate and ISPE’s global headquarters is very good, very strong. But we want to strengthen the relationships linking our local committees with global Communities of Practices, such as those focused on GAMP®. This is very important, but it’s a current weak point.”

The Brazil Affiliate also plans to reach out more to other ISPE Affiliates in the region, particularly Argentina and Mexico. “The ISPE Mexico Affiliate is new, and we’d like to work with them and Argentina on regulatory initiatives within Latin America.” In addition, the Affiliate intends to increase its role within the North America and South America Affiliates and Chapters (NASAC) group.

Conclusion

As he looks forward, Giampietro, who has been an ISPE member since 2006 and is entering the second year of his two-year Affiliate presidency, is excited by the Brazil Affiliate’s positive relationship with ANVISA. “The new ANVISA regulatory movements are very important, and ISPE Brazil will be there to help them whenever they need it.”

He emphasized that the Affiliate’s future success will depend on the commitment of its members. “Our main challenge is for people to find the time to volunteer in ISPE initiatives,” he said. “Some companies allow people to attend ISPE events during business hours, but it takes volunteers time to develop these initiatives—and that has an impact on their private lives. We have the people who will help, but it’s difficult to attend meetings, answer emails, and prepare articles or presentations. To prepare a good one-hour presentation, you may need 20 hours or more.” Recent expansion in the Affiliate suggests that pharma professionals in Brazil are up to this challenge.